Related references
Note: Only part of the references are listed.Excess Body Weight and Cancer-Related Fatigue, Systemic Inflammation, and Serum Lipids in Breast Cancer Survivors
Julia E. Inglis et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2021)
Recent treatment progress of triple negative breast cancer
Yang Chang-Qing et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2020)
Modulating Tumor-Associated Macrophage Polarization by Synthetic and Natural PPARγ Ligands as a Potential Target in Breast Cancer
Giulia Gionfriddo et al.
CELLS (2020)
Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
Francisco Triana-Martinez et al.
CELLS (2020)
n-3 Polyunsaturated Fatty Acid Amides: New Avenues in the Prevention and Treatment of Breast Cancer
Cinzia Giordano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
15d-PGJ2 inhibits NF-κB and AP-1-mediated MMP-9 expression and invasion of breast cancer cell by means of a heme oxygenase-1-dependent mechanism
Hye-Yeon Jang et al.
BMB REPORTS (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
A Comprehensive Review of Autophagy and Its Various Roles in Infectious, Non-Infectious, and Lifestyle Diseases: Current Knowledge and Prospects for Disease Prevention, Novel Drug Design, and Therapy
Rekha Khandia et al.
CELLS (2019)
Pharmacological Treatment of Chemotherapy-Induced Neuropathic Pain: PPARγ Agonists as a Promising Tool
Nara Lins Meira Quintao et al.
FRONTIERS IN NEUROSCIENCE (2019)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Effects of Omega-3 Fatty Acids on Immune Cells
Saray Gutierrez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Influence of Omega-3 Fatty Acids on Skeletal Muscle Protein Turnover in Health, Disuse, and Disease
Chris McGlory et al.
FRONTIERS IN NUTRITION (2019)
Thiazolidinediones as antidiabetic agents: A critical review
M. J. Nanjan et al.
BIOORGANIC CHEMISTRY (2018)
Functional Regulation of PPARs through Post-Translational Modifications
Reinhard Brunmeir et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Troglitazone Inhibits Matrix Metalloproteinase-9 Expression and Invasion of Breast Cancer Cell through a Peroxisome Proliferator-Activated Receptor γ-Dependent Mechanism
On-Yu Hong et al.
JOURNAL OF BREAST CANCER (2018)
Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits
Fereidoon Shahidi et al.
ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 9 (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Targeting the cell cycle in breast cancer: towards the next phase
K. L. Thu et al.
CELL CYCLE (2018)
Signaling Mechanisms of Selective PPAR gamma Modulators in Alzheimer's Disease
Manoj Govindarajulu et al.
PPAR RESEARCH (2018)
Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ
Jinsai Shang et al.
ELIFE (2018)
Autophagy pathway: Cellular and molecular mechanisms
Li Yu et al.
AUTOPHAGY (2018)
Fatigue reduction diet in breast cancer survivors: a pilot randomized clinical trial
Suzanna Maria Zick et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
DHA blocks TPA-induced cell invasion by inhibiting MMP-9 expression via suppression of the PPAR-γ/NF-κB pathway in MCF-7 cells
Jin-Ki Hwang et al.
ONCOLOGY LETTERS (2017)
Vitamin D receptor as a target for breast cancer therapy
Alyson Murray et al.
ENDOCRINE-RELATED CANCER (2017)
Stearoyl-CoA desaturase-1, a novel target of omega-3 fatty acids for reducing breast cancer risk in obese postmenopausal women
A. Manni et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2017)
PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
Veronica Vella et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Cell cycle regulation and anticancer drug discovery
Jingwen Bai et al.
CANCER BIOLOGY & MEDICINE (2017)
Estimating the effects of second-line therapy for type 2 diabetes mellitus: retrospective cohort study
Assaf Gottlieb et al.
BMJ OPEN DIABETES RESEARCH & CARE (2017)
Global Cancer in Women: Burden and Trend
Lindsey A. Torre et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Activation of the Farnesoid X-receptor in breast cancer cell lines results in cytotoxicity but not increased migration potential
Noura Alasmael et al.
CANCER LETTERS (2016)
Fatty acids, eicosanoids and PPAR gamma
Rachel Marion-Letellier et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
The role of background diet on the effects of eicosapentaenoic acid and docosahexaenoic acid supplementation in healthy pre-menopausal women: a randomized, cross-over, controlled study
Megan Arnold Gomes et al.
LIPIDS IN HEALTH AND DISEASE (2016)
Natural Products as Promising Antitumoral Agents in Breast Cancer: Mechanisms of Action and Molecular Targets
Daniela Bonofiglio et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2016)
Dietary DHA and health: cognitive function ageing
Carlos Cardoso et al.
NUTRITION RESEARCH REVIEWS (2016)
PPARgene: A Database of Experimentally Verified and Computationally Predicted PPAR Target Genes
Li Fang et al.
PPAR RESEARCH (2016)
Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression
Daniela Rovito et al.
ONCOTARGET (2016)
Molecular Regulation of Adipogenesis and Potential Anti-Adipogenic Bioactive Molecules
Dorothy Moseti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Omega-3 DHA- and EPA-dopamine conjugates induce PPARγ-dependent breast cancer cell death through autophagy and apoptosis
Daniela Rovito et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Progress in adjuvant chemotherapy for breast cancer: an overview
Jesus Anampa et al.
BMC MEDICINE (2015)
Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer
Rezvan Abduljabbar et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women
Carol J. Fabian et al.
CANCER PREVENTION RESEARCH (2015)
Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Premenopausal Women
Carol J. Fabian et al.
CANCER PREVENTION RESEARCH (2015)
Effect of DHA-rich fish oil on PPARγ target genes related to lipid metabolism in type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial
Anahita Mansoori et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Incorporation of eicosapentaenioic and docosahexaenoic acids into breast adipose tissue of women at high risk of breast cancer: A randomized clinical trial of dietary fish and n-3 fatty acid capsules
Shana Straka et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2015)
Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists
Stephane Prost et al.
NATURE (2015)
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Mark A. Feitelson et al.
SEMINARS IN CANCER BIOLOGY (2015)
Review of the Structural and Dynamic Mechanisms of PPARγ Partial Agonism
Alice J. Kroker et al.
PPAR RESEARCH (2015)
An Ideal PPAR Response Element Bound to and Activated by PPARα
John Tzeng et al.
PLOS ONE (2015)
PPAR gamma gene - A review
C. Janani et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2015)
Omega-3 fatty acids for breast cancer prevention and survivorship
Carol J. Fabian et al.
BREAST CANCER RESEARCH (2015)
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR-γ): a review
Limei Wang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Retinoids and breast cancer: From basic studies to the clinic and back again
Enrico Garattini et al.
CANCER TREATMENT REVIEWS (2014)
PPARγ and RXR Ligands Disrupt the Inflammatory Cross-talk in the Hypoxic Breast Cancer Stem Cells Niche
Alessio Papi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Docosahexaenoic acid inhibited the Wnt/β-Catenin pathway and suppressed breast cancer cells in vitro and in vivo
Meilan Xue et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)
Mammary tumour development is dose-dependently inhibited by n-3 polyunsaturated fatty acids in the MMTV-neu (ndl)-YD5 transgenic mouse model
Michael A. Leslie et al.
LIPIDS IN HEALTH AND DISEASE (2014)
Anticancer Activities of Pterostilbene-Isothiocyanate Conjugate in Breast Cancer Cells: Involvement of PPARγ
Kumar Nikhil et al.
PLOS ONE (2014)
Higher omega-3 index is associated with increased insulin sensitivity and more favourable metabolic profile in middle-aged overweight men
Benjamin B. Albert et al.
SCIENTIFIC REPORTS (2014)
Rivoglitazone: A New Thiazolidinedione for the Treatment of Type 2 Diabetes Mellitus
Robin L. Koffarnus et al.
ANNALS OF PHARMACOTHERAPY (2013)
Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer
Francisco J. Esteva et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF-7 breast cancer cells
Daniela Rovito et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Mammary tumor development is directly inhibited by lifelong n-3 polyunsaturated fatty acids
Mira B. MacLennan et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2013)
The inhibition of early stages of HER-2/neu-mediated mammary carcinogenesis by dietary n-3 PUFAs
Lisa D. Yee et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
Total dietary fat and omega-3 fatty acids have modest effects on urinary sex hormones in postmenopausal women
Lindsay R. Young et al.
NUTRITION & METABOLISM (2013)
The Role of Peroxisome Proliferator-Activated Receptor-γ in Breast Cancer
Ioly Kotta-Loizou et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies
Michael J. Pishvaian et al.
CANCER (2012)
Identification of a Molecular Signature Underlying Inhibition of Mammary Carcinoma Growth by Dietary N-3 Fatty Acids
Weiqin Jiang et al.
CANCER RESEARCH (2012)
Personalized Medicine in Breast Cancer: A Systematic Review
Sang-Hoon Cho et al.
JOURNAL OF BREAST CANCER (2012)
PPARγ as a molecular target of EPA anti-inflammatory activity during TNF-α-impaired skeletal muscle cell differentiation
Peter Magee et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Total dietary fat and fatty acid content modifies plasma phospholipid fatty acids, desaturase activity indices, and urinary prostaglandin E in women
Susan K. Raatz et al.
NUTRITION RESEARCH (2012)
The Nitrated Fatty Acid 10-Nitro-oleate Diminishes Severity of LPS-Induced Acute Lung Injury in Mice
Aravind T. Reddy et al.
PPAR RESEARCH (2012)
Mode of Peroxisome Proliferator-Activated Receptor γ Activation by Luteolin
Ana C. Puhl et al.
MOLECULAR PHARMACOLOGY (2012)
In Vivo and in Vitro Evidence That PPARγ Ligands Are Antagonists of Leptin Signaling in Breast Cancer
Stefania Catalano et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation
Tamas Varga et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Bid as a potential target of apoptotic effects exerted by low doses of PPARγ and RXR ligands in breast cancer cells
Daniela Bonofiglio et al.
CELL CYCLE (2011)
Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy
Kim Henriksen et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Combination of thiazolidinedione and hydralazine suppresses proliferation and induces apoptosis by PPARγ up-expression in MDA-MB-231 cells
Ying Jiang et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
Effect of Dietary Fat and Omega-3 Fatty Acids on Urinary Eicosanoids and Sex Hormone Concentrations in Postmenopausal Women: A Randomized Controlled Feeding Trial
Lindsay R. Young et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2011)
A high-fat diet and the threonine-encoding allele (Thr54) polymorphism of fatty acid-binding protein 2 reduce plasma triglyceride-rich lipoproteins
Steven P. McColley et al.
NUTRITION RESEARCH (2011)
Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression
C. Giordano et al.
ONCOGENE (2011)
Docosahexaenoic Acid Induces Apoptosis in MCF-7 Cells In Vitro and In Vivo via Reactive Oxygen Species Formation and Caspase 8 Activation
Ki Sung Kang et al.
PLOS ONE (2010)
Peroxisome proliferator-activated receptor. and colorectal cancer
Yun Dai et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2010)
Combined Low Doses of PPARγ and RXR Ligands Trigger an Intrinsic Apoptotic Pathway in Human Breast Cancer Cells
Daniela Bonofiglio et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells
Daniela Bonofiglio et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Fish oil targets PTEN to regulate NFκB for downregulation of anti-apoptotic genes in breast tumor growth
Triparna Ghosh-Choudhury et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Repression of NHE1 Expression by PPARγ Activation Is a Potential New Approach for Specific Inhibition of the Growth of Tumor Cells In vitro and In vivo
Alan Prem Kumar et al.
CANCER RESEARCH (2009)
How safe is the use of thiazolidinediones in clinical practice?
C. V. Rizos et al.
EXPERT OPINION ON DRUG SAFETY (2009)
Life and death by death receptors
Maria Eugenia Guicciardi et al.
FASEB JOURNAL (2009)
PPARγ activation induces autophagy in breast cancer cells
Jie Zhou et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
PPARγ and Wnt/β-Catenin pathway in human breast cancer: expression pattern, molecular interaction and clinical/prognostic correlations
Ying Jiang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor γ ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells-potential for dietary modulation of peroxisome proliferator-activated receptor γ in intestinal inflammation
Rachel Marion-Letellier et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2008)
Fat and beyond: The diverse biology of PPAR gamma
Peter Tontonoz et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma
Andrzej Zieleniak et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2008)
Troglitazone enhances tamoxifen-induced growth inhibitory activity of MCF-7 cells
Hong-Nu Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Peroxisome proliferator-activated receptor γ-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells
Haiguo Sun et al.
CANCER RESEARCH (2008)
Peroxisome proliferator-activated receptor γ inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent
D. Bonofiglio et al.
ENDOCRINE-RELATED CANCER (2008)
Sensitization by docosahexaenoic acid (DHA) of breast cancer cells to anthracyclines through loss of glutathione peroxidase (GPx1) response
Sophie Vibet et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity
Xian-Kang Fang et al.
LIFE SCIENCES (2008)
Structural basis for the activation of PPARγ by oxidized fatty acids
Toshimasa Itoh et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Red clover extract: a putative source for simultaneous treatment of menopausal disorders and the metabolic syndrome
Monika Mueller et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2008)
The Role of PPARs in Cancer
Keisuke Tachibana et al.
PPAR RESEARCH (2008)
Omega-3 Fatty Acids and PPAR gamma in Cancer
Iris J. Edwards et al.
PPAR RESEARCH (2008)
Fish consumption, n-3 fatty acids, and colorectal cancer: A meta-analysis of prospective cohort studies
Anouk Geelen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
PPARs and molecular mechanisms of transrepression
Mercedes Ricote et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Effects of thiazolidinediones on differentiation, proliferation, and apoptosis
Fu-Sheng Chou et al.
MOLECULAR CANCER RESEARCH (2007)
Pilot study of rosiglitazone therapy in women with breast cancer: Effects of short-term therapy on tumor tissue and serum markers
Lisa D. Yee et al.
CLINICAL CANCER RESEARCH (2007)
Selective Modulators of PPAR-gamma Activity: Molecular Aspects Related to Obesity and Side-Effects
Fang Zhang et al.
PPAR RESEARCH (2007)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Peroxisome proliferator-activated receptor-γ activates p53 gene promoter binding to the nuclear factor-κB sequence in human MCF7 breast cancer cells
Daniela Bonofiglio et al.
MOLECULAR ENDOCRINOLOGY (2006)
Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat
OP Lazarenko et al.
BONE (2006)
Estrogen receptor α binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor γ signaling in breast cancer cells
D Bonofiglio et al.
CLINICAL CANCER RESEARCH (2005)
Breast cancer metastasis: Markers and models
B Weigelt et al.
NATURE REVIEWS CANCER (2005)
Nitrolinoleic acid:: An endogenous peroxisome proliferator-activated receptor γ ligand
FJ Schopfer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
PPAR gamma expression in breast cancer: clinical value and correlation with ER beta
I Papadaki et al.
HISTOPATHOLOGY (2005)
15-Deoxy-Delta-(12,14)-prostaglandin J(2) induces programmed cell death of breast cancer cells by a pleiotropic mechanism
M Pignatelli et al.
CARCINOGENESIS (2005)
Binding analyses between human PPAR gamma-LBD and ligands - Surface plasmon resonance biosensor assay correlating with circular dichroic spectroscopy determination and molecular docking
CY Yu et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Activation of PPAR γ in colon tumor cell lines by oxidized metabolites of linoleic acid, endogenous ligands for PPAR γ
AW Bull et al.
CARCINOGENESIS (2003)
Hepatic scavenger receptor class B, type I is stimulated by peroxisome proliferator-activated receptor γ and hepatocyte nuclear factor 4α
L Malerod et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Use of the peroxisome proliferator-activated receptor (PPAR) γ ligand troglitazone as treatment for refractory breast cancer:: a phase II study
HJ Burstein et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
PPARγ ligands and ATRA inhibit the invasion of human breast cancer cells in vitro
H Liu et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamina1 in MDA-MB-231 and MCF-7 breast cancer cells
X Wang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Novel therapeutic approach:: ligands for PPARγ and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells
E Elstner et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor γ
C Chambrier et al.
OBESITY RESEARCH (2002)
Loss of the peroxisome proliferation-activated receptor gamma (PPARγ) does not affect mammary development and propensity for tumor formation but leads to reduced fertility
Y Cui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages:: evidence for a PPARγ-dependent mechanism
Y Yu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Peroxisome proliferator-activated receptor gamma (PPAR gamma) and its ligands: A review
KL Houseknecht et al.
DOMESTIC ANIMAL ENDOCRINOLOGY (2002)
The mode of action of thiazolidinediones
H Hauner
DIABETES-METABOLISM RESEARCH AND REVIEWS (2002)
A unique PPARγ ligand with potent insulin-sensitizing yet weak adipogenic activity
S Rocchi et al.
MOLECULAR CELL (2001)
Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators
F Yin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease
YF Guan et al.
KIDNEY INTERNATIONAL (2001)
Inhibition of cellular proliferation through IκB kinase-independent and peroxisome proliferator-activated receptor γ-dependent repression of cyclin D1
CG Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Share Paper
